Medicare Enrolled
Dr. Sonia Eapen, M.D.
Endocrinology · Pearland, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Eapen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Eapen?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Eapen
Dr. Sonia Eapen is an endocrinology specialist in Pearland, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Eapen performed 2,503 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Eapen received a total of $21,640 from 65 pharmaceutical and/or device companies across 915 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Eapen is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 18% volume in TX
$21,640 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,503
Medicare services
Top 18% in TX for endocrinology
Not available
Unique patients (not deduplicated)
$46
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
858 | $91 | $228 |
| Blood glucose level test A test that measures the amount of sugar in your blood. |
665 | $4 | $12 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
562 | $9 | $25 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
214 | $58 | $155 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
83 | $122 | $355 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
51 | $27 | $94 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
36 | $10 | $54 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
17 | $74 | $229 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
17 | $142 | $308 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$21,640
Total received (2018-2024)
Avg $3,091/year across 7 years
Top 21% in TX for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
915
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,319
2023
$2,473
2022
$2,387
2021
$1,753
2020
$3,074
2019
$3,182
2018
$6,453
Payments by company (2024)
Lilly USA, LLC
$363
Novo Nordisk Inc
$358
Antares Pharma, Inc.
$168
AstraZeneca Pharmaceuticals LP
$167
Corcept Therapeutics
$164
Amgen Inc.
$151
Insulet Corporation
$97
Tandem Diabetes Care, Inc.
$92
Boehringer Ingelheim Pharmaceuticals, Inc.
$87
CeQur Corporation
$72
Amphastar Pharmaceuticals, Inc.
$70
Abbott Laboratories
$59
BETA BIONICS, INC.
$55
Novartis Pharmaceuticals Corporation
$54
Amneal Pharmaceuticals LLC
$49
SANOFI-AVENTIS U.S. LLC
$45
Embecta Corp.
$41
Verity Pharmaceuticals Inc.
$33
Dexcom, Inc.
$29
Ascensia Diabetes Care Us Inc.
$23
ABBVIE INC.
$21
Radius Health, Inc.
$20
Tolmar, Inc.
$20
Medicure Pharma Inc.
$18
Ascendis Pharma Inc
$17
IBSA Pharma Inc.
$16
Mannkind Corporation
$16
Esperion Therapeutics, Inc.
$13
Top 3 companies account for 38.3% of 2024 payments
All-time payments by company (2018-2024) ›
Tandem Diabetes Care, Inc.
$6,041
Lilly USA, LLC
$2,188
Novo Nordisk Inc
$2,125
AstraZeneca Pharmaceuticals LP
$2,044
SANOFI-AVENTIS U.S. LLC
$992
Amgen Inc.
$697
Boehringer Ingelheim Pharmaceuticals, Inc.
$637
Dexcom, Inc.
$510
Abbott Laboratories
$453
AbbVie Inc.
$423
Antares Pharma, Inc.
$419
Insulet Corporation
$392
Amneal Pharmaceuticals LLC
$314
CeQur Corporation
$306
AbbVie, Inc.
$280
Radius Health, Inc.
$268
Mannkind Corporation
$246
MannKind Corporation
$205
Novartis Pharmaceuticals Corporation
$192
Embecta Corp.
$190
IBSA Pharma Inc.
$187
Corcept Therapeutics
$186
Merck Sharp & Dohme Corporation
$177
ABBVIE INC.
$169
Janssen Pharmaceuticals, Inc
$155
Valeritas, Inc.
$117
Companion Medical, Inc.
$114
Supernus Pharmaceuticals, Inc.
$106
Shire North American Group Inc
$105
Amarin Pharma Inc.
$93
LifeScan, Inc.
$83
Orexigen Therapeutics, Inc.
$76
Bayer HealthCare Pharmaceuticals Inc.
$75
Alexion Pharmaceuticals, Inc.
$73
Xeris Pharmaceuticals, Inc.
$71
Amphastar Pharmaceuticals, Inc.
$70
DEXCOM, INC.
$68
Ascensia Diabetes Care Us Inc.
$60
BETA BIONICS, INC.
$55
Bayer Healthcare Pharmaceuticals Inc.
$54
Becton, Dickinson and Company
$49
Gemini Laboratories, LLC
$40
Takeda Pharmaceuticals U.S.A., Inc.
$40
Ascendis Pharma Inc
$39
Zealand Pharma US, Inc.
$34
Verity Pharmaceuticals Inc.
$33
Currax Pharmaceuticals LLC
$32
Eisai Inc.
$32
Medtronic, Inc.
$30
Medtronic MiniMed, Inc.
$27
Ultragenyx Pharmaceutical Inc.
$23
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$22
Nevro Corp.
$22
Lexicon Pharmaceuticals, Inc.
$22
PFIZER INC.
$20
Tolmar, Inc.
$20
KVK-Tech, Inc.
$19
Bigfoot Biomedical Inc
$19
Medicure Pharma Inc.
$18
VistaPharm, Inc.
$17
Sun Pharmaceutical Industries Inc.
$16
Nalpropion Pharmaceuticals LLC
$16
Avion Pharmaceuticals
$13
Esperion Therapeutics, Inc.
$13
EISAI INC.
$11
Top 3 companies account for 47.8% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Androgel · BAQSIMI · BASAGLAR · BD Nano · BD Nano 2nd Gen Pen Needle · Belviq · CONTRAVE · CREON · CYCLOSET · CeQur Simplicity · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DIABETES - DISEASE · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · FARXIGA · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN R 500 · INVOKANA · InPen · Inpefa · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LICART · LINZESS · MOUNJARO · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · NP Thyroid 60 · NovoLog · OT Verio Reflect "One Touch Meter and Strips" · OTREXUP · Omnia · Omnipod · OneTouch · Otrexup · Ozempic · PREMARIN · Prolia · RIOMET ER · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SYNJARDY · SYNTHROID · Saxenda · Strensiq · Synthroid · TEPEZZA · TLANDO · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Thyquidity · Tirosint · Tlando · Tresiba · Tymlos · UNITHROID · UNITY DIABETES MANAGEMENT SYSTEM · V-GO · Vascepa · Victoza · Wegovy · XARELTO · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · Zypitamag · iLet Bionic Pancreas · iPro2 · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Endocrinologists in nearby ZIP areas
122
County median income
$95,155
Nearest hospital to ZIP centroid (approximate)
HCA HOUSTON HEALTHCARE PEARLAND
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Eapen is a clinical cardiology specialist, with above-average Medicare volume (top 18% in TX), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Eapen experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Eapen performed 858 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Eapen receive payments from pharmaceutical companies?
Yes. Dr. Eapen received a total of $21,640 from 65 companies across 915 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Eapen's costs compare to other endocrinologists in Pearland?
Dr. Eapen's average Medicare payment per service is $46. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Eapen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Pearland
Browse endocrinologists in Pearland ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in TX
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in TX
Which TX endocrinologists receive the most from drug and device companies.
By company
Tandem Diabetes Care, Inc. Payments to Doctors
See all physicians who received payments from Tandem Diabetes Care, Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology